AMENDMENT NO. 2 TO WARRANT AGREEMENTWarrant Agreement • May 6th, 2016 • Alimera Sciences Inc • Pharmaceutical preparations • New York
THIS AMENDMENT NO. 2 TO WARRANT AGREEMENT is made this 14th day of March, 2016, by and between Hercules Capital, Inc., a Maryland corporation f/k/a Hercules Technology Growth Capital, Inc. (“Warrantholder”) and Alimera Sciences, Inc., a Delaware corporation (the “Company”).
FIRST AMENDED AND RESTATED COMMERCIAL CONTRACT MANUFACTURING AGREEMENT Dated as of February 5, 2016 By and Between Alimera Sciences, Inc. And Alliance Medical Products, Inc. d.b.a. Siegfried IrvineCommercial Contract Manufacturing Agreement • May 6th, 2016 • Alimera Sciences Inc • Pharmaceutical preparations • New York
This FIRST AMENDED AND RESTATED COMMERCIAL CONTRACT MANUFACTURING AGREEMENT (together, with the attachments hereto, this “AGREEMENT”), dated as of February 5, 2016 (the “EFFECTIVE DATE”), by and between Alimera Sciences, Inc., a Delaware corporation (“CUSTOMER”), with offices at 6120 Windward Parkway, Suite 290, Alpharetta, GA 30005 and Alliance Medical Products, Inc. d.b.a. Siegfried Irvine, (“SIEGFRIED”), a California corporation, with offices at 9342 Jeronimo Rd., Irvine, CA 92688.
SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENTLoan and Security Agreement • May 6th, 2016 • Alimera Sciences Inc • Pharmaceutical preparations • New York
This SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT (this “Amendment”), dated as of March 14, 2016 (the “Second Amendment Date”), is by and among (a) ALIMERA SCIENCES LIMITED, a company registered under the laws of England and Wales under company number 08018355 and having its registered office at Centaur House, Ancells Road, Fleet, Hampshire, United Kingdom, GU51 2UJ (“Borrower”), (b) Hercules Capital Funding Trust 2014-1, a statutory trust created and existing under the laws of the State of Delaware (“Lender”) and (c) HERCULES CAPITAL, INC., a Maryland corporation (formerly known as Hercules Technology Growth Capital, Inc.), in its capacity as administrative agent for itself and Lender (in such capacity, the “Agent”).
